SCD and non-small cell lung carcinoma: A recent study revealed that g-PPT could markedly suppress the expression of lipid metabolism key enzyme stearoyl-CoA desaturase 1 (SCD1) and then lower the intracellular lipid droplet content in non-small cell lung cancer (NSCLC).